DCGI Classifies 135 Ophthalmology Related Medical Devices Under MD Rules

New Delhi : The Drugs Controller General (India) has classified 135 medical devices related to ophthalmology under the provisions of Medical Devices Rules, 2017. In another notice, it has also classified 51 medical devices pertaining to respiratory treatments under the provisions of Medical Devices Rules, 2017, the rule formed to regulate them with respect to the import, manufacture, sale and distribution, and clinical investigation.

The drug regulator listed ophthalmology-related medical devices including automated lens meter (dioptometer), bagolini lens, blepharoplasty scissors, contact lens including coloured contact lens, corneal marker, corneal scissors, corneal shield, diagnostic condensing lens, donor cornea container, euthyscope, eye cup, eye muscle clamp, eye pad, eye spud, eyelid clamp, among others.

The DCGI, in in another notice, listed the medical devices including cerebral oximeter, bulk oxygen concentration system, cough long-term ambulatory recording system, dry powder inhaler, foetal pulse oximeter, oxygen concentrator, gas pipeline/supply system air compressor, hypopnea sensor and alarm, infant apnoea monitor, manual chest percussion, nitrogen monoxide analyser, steam inhaler, stress test treadmill, therapeutic positive pressure breathing ventilator, thoracic suction pump, among others under the Medical Devices Rules.

General intended use given against each of the devices is for guidance to the applicants intended to furnish application of import or manufacture of medical devices under the provisions of Medical Devices Rules, 2017. However, a device may have specific intended use as specified by its manufacturer.

The drug regulator has earlier classified 112 medical devices pertaining to anaesthesiology and around 208 medical devices in various categories including rehabilitation, physical support, dermatology and plastic surgery and interventional radiology and another 80 in vitro diagnostic medical devices including analysers, instruments and softwares, from mid July, 2021.

  • Related Posts

    The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

    NEW DELHI: Medical technology innovation is entering a new phase, with advanced cardiac implants, incisionless brain surgery, blood-based cancer screening, smart insulin delivery and real-time kidney-function monitoring among the technologies…

    Three arrested after liquor bottles found at pharma firm

    Patna: Three people were arrested and sent to jail after a large quantity of liquor bottles was found at Cellulas Pharma Private Limited in Kankarbagh during a raid by the…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

    The Most Innovative Medical Devices of 2026: Breakthrough Technologies Target Heart Disease, Cancer, Neurological Disorders and Kidney Dysfunction

    Three arrested after liquor bottles found at pharma firm

    Three arrested after liquor bottles found at pharma firm

    NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

    NEXUS 2026 brings pharma experts together to explore next generation analytical technologies

    National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

    National Formulary of India 2026 Lists Unapproved Drugs; DCGI Seeks Urgent Explanation from IPC Over Regulatory Discrepancy

    Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

    Six leading mental health organisations unite to launch ‘Humanising Medicine India Initiative’ on World Mental Health Day

    Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources

    Cancer Drug Prices May Fall By Up To 70% As Government Caps Trade Margins: Sources